Biotech · Private company
Portal Therapeutics, Inc.
Track this companyFree. Adds Portal Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials42 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- PORT-77Phase 3 · Erythropoietic Protoporphyria (EPP)ClinicalTrials.gov · fetched Nov 12, 2026
- PORT-77Phase 1 · Healthy Adult ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A Study to Investigate PORT-77 Oral Dosing Compared With Placebo in Participants With Erythropoietic Protoporphyria (EPP) or X-linked Protoporphyria (XLP)PHASE2_PHASE3 · RECRUITING · started Sep 1, 2026ClinicalTrials.gov NCT07820085 · fetched Nov 12, 2026
- Observational Study of Adults and Adolescents With Erythropoietic Protoporphyria (EPP) and X-linked Porphyria (XLP)RECRUITING · started Apr 30, 2026ClinicalTrials.gov NCT07567131 · fetched Nov 12, 2026
- GATEWAY: A Phase 2a Study of PORT-77 in Adults With Erythropoietic ProtoporphyriaPHASE2 · COMPLETED · started Apr 4, 2025ClinicalTrials.gov NCT06971900 · fetched Nov 12, 2026
- Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study of PORT-77 Administered to Healthy Adult ParticipantsPHASE1 · COMPLETED · started Apr 8, 2024ClinicalTrials.gov NCT06346509 · fetched Nov 12, 2026